Clinical Trial

Are Rates of Colectomies, Resections, Mortalities and Cancer Reduced by Home Monitoring of IBD Patients ?

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study is a side protocol/extension of 10 years of ClinicalTrials.gov ID: NCT02492555. The purpose of this study is to determine if the IBD patients doing home monitoring (screening themselves on demand (OD) or every 3 months) have relative reduced rates of colectomies, resections, mortalities and cancer after 11 years of web monitoring. The IBD patients are self-monitoring by web apps consisting of a short disease activity questionnaire (DA) and fecal calprotectin (FC) on any smart phone.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2017-01-30; most recent amendment 2022-04-14.
Trial Details
NCT Number NCT03038984
Lead Sponsor Nordsjaellands Hospital
Conditions Inflammatory Bowel Diseases
Enrollment 120 participants
Start Date 2016-08
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2022-04-15